BARCELONA, Spain — Women with inoperable early-stage endometrial cancer survive longer if their treatment includes brachytherapy (BT) rather than external beam radiotherapy (EBRT) alone, according to ...
March 8, 2010 — Women with endometrial cancer of high-intermediate risk, who comprise about 30% of the patient population, can be safely treated with vaginal brachytherapy (VBT) after surgery instead ...
Women who have early stage endometrial cancer and are inoperable tend to live longer if they have been treated with brachytherapy with or without external beam radiation, according to new research to ...
Women with stage 1 endometrioid adenocarcinoma of the uterus showed improved survival with vaginal brachytherapy (VB), according to a large database analysis published in the journal Cancer. Women ...
External Beam, Brachytherapy, or Chemotherapy? Defining Adjuvant Therapy for Early-Stage and High- and High–Intermediate-Risk Endometrial Cancer The following represents disclosure information ...
Endometrial cancer is a disease that begins in the lining of the uterus. The primary treatment for endometrial cancer is surgery, including the removal of the uterus, cervix, and upper vagina.
CHICAGO, June 1 -- Vaginal brachytherapy is as effective in preventing a recurrence of endometrial cancer after surgery in women with high-intermediate risk disease as external-beam pelvic ...
A new study finds that brachytherapy, a common procedure that delivers radiation directly to cancer cells, may continue safely, potentially without delay or antibiotics, in cervical cancer patients ...
Please provide your email address to receive an email when new articles are posted on . Results of the PORTEC-2 trial indicate that patients with endometrial cancer treated with vaginal brachytherapy ...
Women who have early stage endometrial cancer and are inoperable tend to live longer if they have been treated with brachytherapy with or without external beam radiation, according to new research.
A new study finds that brachytherapy, a common procedure that delivers radiation directly to cancer cells, may continue safely, potentially without delay or antibiotics, in cervical cancer patients ...